Header Logo

Connection

Kimberly Yonkers to Antidepressive Agents

This is a "connection" page, showing publications Kimberly Yonkers has written about Antidepressive Agents.
Connection Strength

3.750
  1. Yonkers KA, Forray A, Smith MV. Maternal Antidepressant Use and Pregnancy Outcomes. JAMA. 2017 08 15; 318(7):665-666.
    View in: PubMed
    Score: 0.494
  2. Yonkers KA, Smith MV, Forray A, Epperson CN, Costello D, Lin H, Belanger K. Pregnant women with posttraumatic stress disorder and risk of preterm birth. JAMA Psychiatry. 2014 Aug; 71(8):897-904.
    View in: PubMed
    Score: 0.400
  3. Yonkers KA, Blackwell KA, Glover J, Forray A. Antidepressant use in pregnant and postpartum women. Annu Rev Clin Psychol. 2014; 10:369-92.
    View in: PubMed
    Score: 0.382
  4. Smith MV, Sung A, Shah B, Mayes L, Klein DS, Yonkers KA. Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors. Early Hum Dev. 2013 Feb; 89(2):81-6.
    View in: PubMed
    Score: 0.352
  5. Yonkers KA, Gotman N, Smith MV, Forray A, Belanger K, Brunetto WL, Lin H, Burkman RT, Zelop CM, Lockwood CJ. Does antidepressant use attenuate the risk of a major depressive episode in pregnancy? Epidemiology. 2011 Nov; 22(6):848-54.
    View in: PubMed
    Score: 0.331
  6. Yonkers KA. The treatment of women suffering from depression who are either pregnant or breastfeeding. Am J Psychiatry. 2007 Oct; 164(10):1457-9.
    View in: PubMed
    Score: 0.249
  7. Yonkers KA, Pearlstein T, Fayyad R, Gillespie JA. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase. J Affect Disord. 2005 Apr; 85(3):317-21.
    View in: PubMed
    Score: 0.209
  8. Brawman-Mintzer O, Yonkers KA. New trends in the treatment of anxiety disorders. CNS Spectr. 2004 Aug; 9(8 Suppl 7):19-27.
    View in: PubMed
    Score: 0.200
  9. Pearlstein T, Yonkers KA. Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder. Expert Opin Pharmacother. 2002 Jul; 3(7):979-91.
    View in: PubMed
    Score: 0.173
  10. Yonkers KA, Brawman-Mintzer O. The pharmacologic treatment of depression: is gender a critical factor? J Clin Psychiatry. 2002 Jul; 63(7):610-5.
    View in: PubMed
    Score: 0.173
  11. Yonkers KA, Clark RH, Trivedi MH. The psychopharmacological treatment of nonmajor mood disorders. Mod Probl Pharmacopsychiatry. 1997; 25:146-66.
    View in: PubMed
    Score: 0.118
  12. Yonkers KA. Antidepressants in the treatment of premenstrual dysphoric disorder. J Clin Psychiatry. 1997; 58 Suppl 14:4-10; discussion 11-3.
    View in: PubMed
    Score: 0.118
  13. Yonkers KA, Halbreich U, Freeman E, Brown C, Pearlstein T. Sertraline in the treatment of premenstrual dysphoric disorder. Psychopharmacol Bull. 1996; 32(1):41-6.
    View in: PubMed
    Score: 0.110
  14. Huang H, Coleman S, Bridge JA, Yonkers K, Katon W. A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight. Gen Hosp Psychiatry. 2014 Jan-Feb; 36(1):13-8.
    View in: PubMed
    Score: 0.094
  15. Yonkers KA, Vigod S, Ross LE. Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women. Obstet Gynecol. 2011 Apr; 117(4):961-977.
    View in: PubMed
    Score: 0.079
  16. Yonkers KA, Wisner KL, Stewart DE, Oberlander TF, Dell DL, Stotland N, Ramin S, Chaudron L, Lockwood C. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen Hosp Psychiatry. 2009 Sep-Oct; 31(5):403-13.
    View in: PubMed
    Score: 0.071
  17. Fabrizio VA, Lindsay CV, Wilcox M, Hong S, Lynn T, Norwitz ER, Yonkers KA, Abrahams VM. The serotonin reuptake inhibitor fluoxetine induces human fetal membrane sterile inflammation through p38 MAPK activation. J Reprod Immunol. 2023 02; 155:103786.
    View in: PubMed
    Score: 0.045
  18. Yonkers KA. Medical management of premenstrual dysphoric disorder. J Gend Specif Med. 1999 May-Jun; 2(3):55-60.
    View in: PubMed
    Score: 0.035
  19. Kocsis JH, Zisook S, Davidson J, Shelton R, Yonkers K, Hellerstein DJ, Rosenbaum J, Halbreich U. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. Am J Psychiatry. 1997 Mar; 154(3):390-5.
    View in: PubMed
    Score: 0.030
  20. Shelton RC, Davidson J, Yonkers KA, Koran L, Thase ME, Pearlstein T, Halbreich U. The undertreatment of dysthymia. J Clin Psychiatry. 1997 Feb; 58(2):59-65.
    View in: PubMed
    Score: 0.030
  21. Yonkers KA, White K. Premenstrual exacerbation of depression: one process or two? J Clin Psychiatry. 1992 Aug; 53(8):289-92.
    View in: PubMed
    Score: 0.022
  22. Yonkers KA, Kando JC, Cole JO, Blumenthal S. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry. 1992 May; 149(5):587-95.
    View in: PubMed
    Score: 0.021
  23. Pearlstein T, Yonkers KA, Fayyad R, Gillespie JA. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. J Affect Disord. 2005 Apr; 85(3):275-82.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.